# Trade Mark Journal No.2026/007 13 February 2026

## WO0000001898854 (5,42)

Office of origin: France

Date of International Registration:14 October 2025
Date of designation in the UK: 14 October 2025

International priority date claimed: 16 April 2025 (France) (5139596)

Class 5
  Pharmaceutical products; monoclonal antibodies for medical, pharmaceutical and therapeutic use; chemical and biological preparations, for therapeutic, medical, pharmaceutical use; diagnostic preparations for therapeutic and medical use; chemical reagents for medical use; reagents for development of monoclonal antibodies for medical use.
Class 42
  Scientific research for medical purposes; biological research; biochemical research; research and development services for pharmaceutical preparations; conducting clinical trials; clinical research; conducting scientific studies and analyses; biological, biotechnological, biochemical, medical and pharmaceutical research and development services for third parties; evaluation of the efficacy of pharmaceutical products.

SPIKIMM

Representative: Madame TERTRAIS Marion IPSILON, 12 Avenue d'Italie, F-75013 PARIS, FRANCE